Apheresis Equipment Market
Number of pages: 100 | Report Format: PDF | Published date: March 23, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 2.83 billion |
|
Revenue Forecast in 2031 |
US$ 6.57 billion |
|
Growth Rate |
9.8% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Procedure, Technology, Application, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global apheresis equipment market was valued at US$ 2.83 billion in 2022 and is expected to register a revenue CAGR of 9.8% to reach US$ 6.57 billion by 2031.
Apheresis Equipment Market Fundamentals
An apheresis procedure involves removing blood from a patient, separating its components, such as red blood cells, plasma, or platelets, and returning certain components to the patient. This procedure helps in the treatment of various medical conditions, including autoimmune disorders, cancer, and blood disorders. Apheresis equipment is critical in ensuring the safety and effectiveness of apheresis treatments. Apheresis equipment comprises several components, including a machine, a disposable kit, and various monitoring devices. Centrifugation and membrane separation are the main separation technologies used in apheresis. The key trends observed in the global apheresis market are increasing demand for plasma products, technological advancements in apheresis techniques, increasing applications of apheresis in various treatments, and growing awareness about apheresis.
[57567]
Apheresis Equipment Market Dynamics
The continuously changing healthcare market and increased expenditures have permitted technical advances in the creation of next-generation apheresis systems and equipment. Advanced technologies are more efficient, with screen navigation, graphical user interfaces, and automated interface systems that enable time efficiency and eliminate human errors. It also helps to reduce pathogen contamination of plasma and platelet components, lowering the likelihood of patients suffering from transfusion-transmitted illnesses. Hence, increased awareness of apheresis donations and their advantages and a favorable regulatory environment are expected to drive market expansion throughout the forecast period.
The increasing need for apheresis to treat different disorders, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and neonatal cardiac lupus, is propelling market revenue growth. Apart from this, an increase in the usage of apheresis to collect plasma for treating burn and trauma patients worldwide is driving revenue growth in the market. The growing need for source plasma to treat primary immunodeficiency and hemophilia presents industry investors with significant growth potential. Moreover, the increasing usage of apheresis as a treatment for various disorders, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is providing a promising market outlook.
However, apheresis equipment can be expensive and a significant barrier to adoption, particularly in developing countries with limited healthcare budgets. Apheresis procedures require specialized knowledge and expertise, and there is a shortage of trained professionals who can perform these procedures. These devices are subject to rigorous regulatory requirements, which can slow approval and increase costs. Despite the benefits of apheresis, many healthcare providers and patients are unaware of the technology or its potential applications. Reimbursement policies can vary widely depending on the country or region, impacting the adoption of apheresis equipment. Moreover, apheresis is not the only treatment option for many conditions it is used to treat. Other therapies, such as drug treatments, may be more cost-effective or have fewer side effects, which can limit the revenue growth of the apheresis market.
Apheresis Equipment Market Ecosystem
The global apheresis equipment market has been analyzed from five perspectives: product, procedure, technology, application, and region.
Apheresis Equipment Market by Product
[85675]
Based on product, the global apheresis equipment market can be segmented into devices and disposables.
The disposable segment dominated the market in 2022 with the highest revenue share. It is expected to retain its dominance during the forecast period due to significant advancements in manufacturing blood bags, disposable kits, and tubing. The segment's development is driven by the rising demand for automated component separation methods, particularly in developed economies. Patients with thrombocytopenia and substantially decreased platelet function are the most likely to utilize disposable kits. As a result, the availability of high-quality kits for the best patient care is expected to drive industry growth. Additionally, the increased use of disposable apheresis kits due to their low cost has resulted in a range of services for small producers. Filters, separators, tubing sets, and other components are assembled as kits. Some variables contributing to its huge proportion include high usage volume and fast-expanding demand for apheresis operations. Furthermore, single-use helps to decrease device-related blood infections in donors and patients, which boosts the market revenue growth.
Apheresis Equipment Market by Procedure
Based on procedure, the global apheresis equipment market can be segmented into leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis, photopheresis, and others.
The plasmapheresis segment dominates the global apheresis equipment market. It is a widely used therapeutic and diagnostic procedure in various medical conditions, including autoimmune diseases, neurological disorders, hematology, and renal diseases. In plasmapheresis, the plasma is separated from the blood and replaced with a substitute solution, such as saline or albumin. This process removes harmful substances from the plasma, such as antibodies, immune complexes, or toxins. It can also collect plasma for further processing into plasma-derived products. An increase in the prevalence of autoimmune disorders and chronic diseases, such as multiple sclerosis, lupus, and myasthenia gravis, drives the demand for plasmapheresis. In addition, the rising number of plasma donation centers and the increasing usage of plasma-derived products, such as immunoglobulins, drive the plasmapheresis market segment revenue growth. Furthermore, technological advancements in apheresis equipment, such as the development of automated and portable devices, have made plasmapheresis more convenient and accessible for patients and healthcare providers. This has also fueled the demand for plasmapheresis equipment in the market.
Apheresis Equipment Market by Technology
Based on the technology, the global apheresis equipment market can be segmented into centrifugal apheresis and membrane separation.
The centrifugal apheresis segment registered the largest revenue share in 2022. Centrifugal apheresis is a highly effective method that allows for an extraction rate of blood plasma. The procedure may be performed as a continuous or intermittent flow and requires lower blood flow rates, allowing it to be performed using either central or peripheral venous access. Continuous flow centrifugation can separate, process, and re-infuse blood components simultaneously. The multifunctionality provides substantial time savings but requires two vascular access points. It is preferable to the intermittent flow centrifugation approach, which requires repeated cycles of blood collection, separation, processing, and re-infusion. Using only one vascular access point takes a substantially longer time.
Apheresis Equipment Market by Application
Based on the application, the global apheresis equipment market can be segmented into neurological disorders, renal disorders, hematological disorders, autoimmune disorders, and others.
The neurological disorders segment dominates the global apheresis equipment market due to the high incidence of neurological disorders and the increase in demand for apheresis procedures to treat these disorders. Neurological disorders, such as multiple sclerosis, Guillain-Barré syndrome, and myasthenia gravis, require treatment with apheresis, which involves the removal of blood components, such as plasma or white blood cells, to eliminate harmful antibodies and reduce inflammation. Additionally, there is an increasing prevalence of autoimmune diseases. The development of advanced apheresis equipment and the growing adoption of these devices in hospitals and clinics has also driven the growth of the neurology segment. These factors have made the neurology segment dominant in the global apheresis equipment market.
Apheresis Equipment Market by Region
Based on the region, the global apheresis equipment market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Asia Pacific is estimated to be the fastest-growing regional market for apheresis equipment. The market revenue growth in Asia Pacific can be attributed to the robust expansion of the healthcare industry and the increased expenditures in R&D activities by the leading pharmaceutical and biotechnology businesses. Asia Pacific has demonstrated great development potential in its medical and healthcare industries. The healthcare infrastructure has experienced significant adjustments and improvements. It has demonstrated readiness to absorb innovative technology and medical gadgets. It has been the site of breakthroughs in innovative pharmacological therapies and patient-centered treatments. Countries such as India and China have exhibited promising improvements in recent years, which are expected to add to regional market revenue growth.
Apheresis Equipment Market Competitive Landscape
The prominent players operating in the global apheresis equipment market are:
Apheresis Equipment Market Strategic Developments
The global apheresis equipment market is expected to grow at a revenue CAGR of 9.8% during the forecast period.
Fresenius SE & Co. KGaA, Asahi Kasei Corporation, and B. Braun SE are among the key players operating in the global apheresis equipment market.
The disposables segment dominates the global apheresis equipment market.
Asia Pacific is expected to observe the highest revenue growth in the apheresis equipment market during the forecast period.
The global apheresis equipment market was valued at US$ 2.83 billion in 2022.
*Insights on financial performance are subject to the availability of information in the public domain